Tyra Biosciences (TYRA)Farallon Capital Management, L.L.C. added to its stake +923K shares

2.07M

Shares reported · +923K vs prior quarter

0.25%

Disclosed portfolio weight

$54.3M

Reported value

Holdings as of

Dec 31, 2025

Filed

May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Apr 1, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 1, 2026, the Board of Directors of Tyra Biosciences, Inc. (the Company) designated Julia Rueb, Vice President, Finance of the Company, as the Company’s principal accounting officer, succeeding Alan Fuhrman, the Company’s Chief Financial Officer, in that role, each effective as of April 1, 2026.”
2. Apr 16, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 16, 2026, upon the recommendation of the Nominating and Corporate Governance Committee of the board of directors (the Board) of Tyra Biosciences, Inc. (the Company), and pursuant to the amended and restated bylaws of the Company, the Board approved an increase in the number of authorized directors from nine to ten and appointed Habib J. Dable to the Board as a Class II director with an initial term expiring…”
3. May 13, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Aug 4, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Tyra Biosciences

For Tyra Biosciences, OQRO holds 5 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TYRA page.

How this filing works

• SEC Form 13F

Other disclosures at Tyra Biosciences

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 13, 2026
• SEC Form 13F-HRMay 15, 2026

Everything OQRO holds on this company is on its TYRA page.